Accuray Incorporated (ARAY)

Accuray (ARAY) Stock Price & Analysis


ARAY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.70 - $3.58
Previous Close$2.78
Average Volume (3M)339.99K
Market Cap
Enterprise Value$405.13M
Total Cash (Recent Filing)$67.73M
Total Debt (Recent Filing)$207.38M
Price to Earnings (P/E)-22.0
Apr 25, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding95,494,729
10 Day Avg. Volume436,091
30 Day Avg. Volume339,989
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)-47.00
Price to Sales (P/S)0.71
Price to Cash Flow (P/CF)43.10
P/FCF Ratio-6.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.97
Enterprise Value/Gross Profit2.53
Enterprise Value/Ebitda109.29
Price Target Upside150.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Accuray Incorporated’s price range in the past 12 months?
Accuray Incorporated lowest stock price was $1.70 and its highest was $3.58 in the past 12 months.
    What is Accuray Incorporated’s market cap?
    Currently, no data Available
    When is Accuray Incorporated’s upcoming earnings report date?
    Accuray Incorporated’s upcoming earnings report date is Apr 25, 2023 which is in 35 days.
      How were Accuray Incorporated’s earnings last quarter?
      Accuray Incorporated released its earnings results on Feb 01, 2023. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.026 by $0.006.
        Is Accuray Incorporated overvalued?
        According to Wall Street analysts Accuray Incorporated’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Accuray Incorporated pay dividends?
          Accuray Incorporated does not currently pay dividends.
          What is Accuray Incorporated’s EPS estimate?
          Accuray Incorporated’s EPS estimate is -$0.01.
            How many shares outstanding does Accuray Incorporated have?
            Accuray Incorporated has 95,494,730 shares outstanding.
              What happened to Accuray Incorporated’s price movement after its last earnings report?
              Accuray Incorporated reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.026. Following the earnings report the stock price went up 17.551%.
                Which hedge fund is a major shareholder of Accuray Incorporated?
                Among the largest hedge funds holding Accuray Incorporated’s share is Royce & Associates LLC. It holds Accuray Incorporated’s shares valued at 6M.


                  Accuray Stock Smart Score

                  The Accuray stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Accuray Incorporated

                  Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  ClearPoint Neuro
                  Hamilton Thorne
                  Semler Scientific
                  Zomedica Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis